What It’s Like to Build a Patient-Friendly Pharmacological Unit with Oren Cohen
In this episode, Maya meets Dr. Oren Cohen, who brings more than 30 years of healthcare, research, and clinical development experience to his role, including several senior medical and operational leadership positions at a biotechnology company and another global CRO.
Oren is President at Fortrea Inc which has patient-friendly clinical research units in US and the UK. A hot topic is the unit in Leeds. It’s state of the art as Oren himself describes it. Created with patients in mind, this center is a true example in the industry. Would it resolve the patient recruitment challenge? Has Fortrea paved the way for the future of clinical trials?
Maya and Oren unravel the secret sauce to success and much more in the latest episode. Watch it to learn about:
(0:55) What’s Dr. Oren Cohen’s Professional Experience
(2:37) Why Is Fortrea’s Unit in Leeds So Special
(8:20) How Critical Is the Unit’s Structure to Trials Efficiency
(14:10) Can We Replicate Fortrea’s Success in Leeds Elsewhere
(16:57) Lessons Learned from Building a Patient-Friendly Pharmacological Unit
(22:14) The #1 Thing to Make Trials More Patient-Friendly
Maya Zlatanova, CEO of TrialHub
Dr Oren Cohen, President, Clinical Pharmacology Services and Chief Medical Officer at Fortrea Inc.
- (00:55) - What’s Dr. Oren Cohen’s Professional Experience
- (02:37) - Why Is Fortrea’s Unit in Leeds So Special
- (08:20) - How Critical Is the Unit’s Structure to Trials Efficiency
- (14:10) - Can We Replicate Fortrea’s Success in Leeds Elsewhere
- (16:57) - Lessons Learned from Building a Patient-Friendly Pharmacological Unit
- (22:14) - The #1 Thing to Make Trials More Patient-Friendly
